Scott Hirsch Joins SOLIUS Board of Directors – Life Science Partner

Former CEO of Solta Medical joins SOLIUS Board of Directors.

Life Science Partner is proud to have recruited Scott Hirsch to join the SOLIUS Board of Directors. With extensive experience leading medical device companies and steering business units to success, Hirsch brings a wealth of regulatory expertise and business acumen to SOLIUS.

In collaboration with newly appointed CEO Chris Kiple, JD, Hirsch will assist in fundraising, scaling operations, and launching SOLIUS’ proprietary UVB light therapy technology, designed to treat patients with low Vitamin D levels, including a groundbreaking at-home therapy device.

Hirsch’s Professional Background

Hirsch was drawn to SOLIUS following Valeant’s $250 million acquisition of Solta Medical, a former division of Bausch Health Companies, where Hirsch spearheaded significant achievements. Solta became a recognized leader in the aesthetics industry with a portfolio of products that included the popular Thermage®, Fraxel®, Clear + Brilliant®, and VASERlipo® systems. Hirsch’s expertise in direct-to-consumer business models will drive SOLIUS’ commercialization and regulatory strategies.

“With an impressive background in financing and a proven track record for executing innovative commercialization plans, Hirsch’s strategic vision and dynamic leadership will play a crucial role in SOLIUS’ success,” says Tom Callaway, MD, Founder of Life Science Partner.

Before his tenure as CEO of Solta, Hirsch held leadership roles across several Bausch business units, including President of the Bausch Foundation, President of Ortho Dermatologics, and OraPharma.

Before that, Hirsch was an investor and portfolio manager on Wall Street at Citadel and was Vice President at Plural Investments. He also held the position of Lead Equity Research Analyst for Specialty Pharmaceuticals and Global Generics at Credit Suisse.

Hirsch holds a Bachelor of Fine Arts from the Rhode Island School of Design and an MBA in Finance and Healthcare Management from The Wharton School.

Life Science Partner is also pleased to announce the recruitment of Chris Kiple, JD, former CEO of Ventec Life Systems, as SOLIUS’s Chief Executive Officer.